This new HIV drug kills 99% of the virus in 4 weeks

Human Immunodeficiency Virus (HIV) was first identified in the early 1980s and has since become a global pandemic. The virus attacks the immune system, specifically targeting CD4 cells, weakening the body’s ability to fight infections and diseases.

Over the years, significant progress has been made in understanding and managing HIV, leading to the development of antiretroviral therapies that have transformed HIV from a life-threatening condition to a chronic, manageable disease.

Gammora is a novel HIV drug that has shown promising results in early clinical trials. Developed by Zion Medical, Gammora works by targeting and destroying HIV-infected cells without harming healthy cells. This unique mechanism of action sets Gammora apart from traditional antiretroviral drugs and has sparked optimism in the medical community regarding its potential to contribute to HIV treatment and management.

In Southeast Asia, the prevalence of HIV remains a significant public health concern. According to the HIV/AIDS and Art Registry of the Philippines (HARP), the Philippines has seen a steady increase in HIV cases, with a reported average of 35 new infections daily. This trend underscores the importance of ongoing efforts to raise awareness, improve access to testing and treatment, and combat the stigma associated with HIV.

Beyond Gammora, ongoing research on HIV spans a wide range of areas, including the development of new antiretroviral therapies, HIV prevention strategies such as vaccines and pre-exposure prophylaxis (PrEP), and the exploration of functional cures and eradication approaches. The global scientific community remains dedicated to advancing our understanding of HIV and improving the lives of those affected by the virus.

Several organizations in the Philippines are actively involved in providing support and resources to individuals living with HIV. These include the Department of Health (DOH), which oversees HIV/AIDS prevention and control programs, as well as various non-governmental organizations and advocacy groups focused on HIV awareness, education, and community outreach. Their collective efforts play a crucial role in addressing the multifaceted challenges associated with HIV in the region.